Martín-Delgado Fernando
Director/Board Member bei PHARMA MAR, S.A.
Profil
Martín-Delgado Fernando is currently the Director at Pharma Mar SA. Prior to this, he was the Chief Executive Officer & Director at GENOMICA SA (Spain) from 2021 to 2022.
He also held positions as the Marketing Director at Rhône-Poulenc, Inc., Product Manager at GSK Plc, General Manager at Almirall De Mexico, S.A.
De C.V.
from 2013 to 2016, and General Manager at Syneos Health Clinical Spain SLU from 2021 to 2022.
Additionally, he served as the Vice President & General Manager at IQVIA from 2001 to 2012.
Mr. Fernando is a Founding Partner at Mdsan Farmainvest SL.
He obtained his undergraduate degree from Universidad Autónoma de Madrid in 1983.
Aktive Positionen von Martín-Delgado Fernando
| Unternehmen | Position | Beginn |
|---|---|---|
| PHARMA MAR, S.A. | Director/Board Member | 21.12.2022 |
Ehemalige bekannte Positionen von Martín-Delgado Fernando
| Unternehmen | Position | Ende |
|---|---|---|
GENOMICA SA (Spain)
 GENOMICA SA (Spain) Miscellaneous Commercial ServicesCommercial Services GENOMICA SAU provides genetic identification and molecular diagnostic services. Its services include paternity tests, fornsic genetics technological transfers and laboratory genetic identification for criminal investigation. The firm also offers various diagnostic kits and reagents such as CLART PneumoVir, CLINICAL ARRAYS Metabona and CLINICAL ARRAYS-Papillomavirus. It also provides laboratory installation and technical support services and training courses for laboratory, clinical and forensics professionals. The company was founded in 1990 and is headquartered in Madrid, Spain. | Chief Executive Officer | 01.11.2022 |
| Syneos Health Clinical Spain SLU | Corporate Officer/Principal | 01.01.2022 |
Almirall De Mexico, S.A. De C.V.
 Almirall De Mexico, S.A. De C.V. Pharmaceuticals: MajorHealth Technology Almirall De Mexico, S.A. De C.V. operates as pharmaceutical company, which engages in the research and development of medicines and medical devices for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company is headquartered in Mexico City, Mexico. | Corporate Officer/Principal | 01.01.2016 |
| IQVIA | Corporate Officer/Principal | 01.01.2012 |
| Rhône-Poulenc, Inc. | Sales & Marketing | 01.01.1988 |
Ausbildung von Martín-Delgado Fernando
| Universidad Autónoma de Madrid | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| GSK PLC | Health Technology |
| PHARMA MAR, S.A. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
GENOMICA SA (Spain)
GENOMICA SA (Spain) Miscellaneous Commercial ServicesCommercial Services GENOMICA SAU provides genetic identification and molecular diagnostic services. Its services include paternity tests, fornsic genetics technological transfers and laboratory genetic identification for criminal investigation. The firm also offers various diagnostic kits and reagents such as CLART PneumoVir, CLINICAL ARRAYS Metabona and CLINICAL ARRAYS-Papillomavirus. It also provides laboratory installation and technical support services and training courses for laboratory, clinical and forensics professionals. The company was founded in 1990 and is headquartered in Madrid, Spain. | Commercial Services |
| Rhône-Poulenc, Inc. | Process Industries |
Almirall De Mexico, S.A. De C.V.
Almirall De Mexico, S.A. De C.V. Pharmaceuticals: MajorHealth Technology Almirall De Mexico, S.A. De C.V. operates as pharmaceutical company, which engages in the research and development of medicines and medical devices for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company is headquartered in Mexico City, Mexico. | Health Technology |
| Syneos Health Clinical Spain SLU | |
| IQVIA |
